Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
33.6M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
319K
-
Shares change
-
+162K
-
Total reported value, excl. options
-
$363K
-
Value change
-
+$332K
-
Number of buys
-
18
-
Number of sells
-
-2
-
Price
-
$1.14
Significant Holders of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) as of Q3 2024
21 filings reported holding CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 319K shares
of 33.6M outstanding shares and own 0.95% of the company stock.
Largest 10 shareholders include Cable Car Capital LLC (82.9K shares), CPR Investments Inc. (56K shares), Red Wave Investments LLC (46.5K shares), GEODE CAPITAL MANAGEMENT, LLC (39.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (23.5K shares), Delta Investment Management, LLC (21K shares), Finepoint Capital LP (12.5K shares), Apollo Management Holdings, L.P. (12.5K shares), EVERMAY WEALTH MANAGEMENT LLC (6.34K shares), and HIGHBRIDGE CAPITAL MANAGEMENT LLC (6.25K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.